カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のレナリドミドカプセル市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Lenalidomide Capsule Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19713）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19713
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のレナリドミドカプセル市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

レナリドミドカプセル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のレナリドミドカプセルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

レナリドミドカプセル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル

用途別セグメントは次のように区分されます。
・多発性骨髄腫（MM）、骨髄異形成症候群（MDS）

世界のレナリドミドカプセル市場の主要な市場プレーヤーは以下のとおりです。
・Celgene、SL Pharma、Qilu Pharma、Hansoh Pharma、CTTQ、Changzhou Pharma、Yangzijiang

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、レナリドミドカプセル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なレナリドミドカプセルメーカーの企業概要、2019年～2022年までのレナリドミドカプセルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なレナリドミドカプセルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別レナリドミドカプセルの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのレナリドミドカプセルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのレナリドミドカプセル市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびレナリドミドカプセルの産業チェーンを掲載しています。
・第13、14、15章では、レナリドミドカプセルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- レナリドミドカプセルの概要
- 種類別分析（2017年vs2021年vs2028年）：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル
- 用途別分析（2017年vs2021年vs2028年）：多発性骨髄腫（MM）、骨髄異形成症候群（MDS）
- 世界のレナリドミドカプセル市場規模・予測
- 世界のレナリドミドカプセル生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Celgene、SL Pharma、Qilu Pharma、Hansoh Pharma、CTTQ、Changzhou Pharma、Yangzijiang
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル
・用途別分析2017年-2028年：多発性骨髄腫（MM）、骨髄異形成症候群（MDS）
・レナリドミドカプセルの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・レナリドミドカプセルのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・レナリドミドカプセルのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・レナリドミドカプセルの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・レナリドミドカプセルの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Lenalidomide Capsule market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lenalidomide Capsule market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Multiple myeloma (MM) accounting for % of the Lenalidomide Capsule global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5 mg Capsules segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lenalidomide Capsule include Celgene, SL Pharma, Qilu Pharma, Hansoh Pharma, and CTTQ, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lenalidomide Capsule market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules
Market segment by Application can be divided into
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)
The key market players for global Lenalidomide Capsule market are listed below:
Celgene
SL Pharma
Qilu Pharma
Hansoh Pharma
CTTQ
Changzhou Pharma
Yangzijiang
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lenalidomide Capsule product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lenalidomide Capsule, with price, sales, revenue and global market share of Lenalidomide Capsule from 2019 to 2022.
Chapter 3, the Lenalidomide Capsule competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lenalidomide Capsule breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lenalidomide Capsule market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lenalidomide Capsule.
Chapter 13, 14, and 15, to describe Lenalidomide Capsule sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Lenalidomide Capsule Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lenalidomide Capsule Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5 mg Capsules
1.2.3 10 mg Capsules
1.2.4 15 mg Capsules
1.2.5 25 mg Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Lenalidomide Capsule Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Multiple myeloma (MM)
1.3.3 Myelodysplastic syndromes (MDS)
1.4 Global Lenalidomide Capsule Market Size & Forecast
1.4.1 Global Lenalidomide Capsule Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lenalidomide Capsule Sales in Volume (2017-2028)
1.4.3 Global Lenalidomide Capsule Price (2017-2028)
1.5 Global Lenalidomide Capsule Production Capacity Analysis
1.5.1 Global Lenalidomide Capsule Total Production Capacity (2017-2028)
1.5.2 Global Lenalidomide Capsule Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lenalidomide Capsule Market Drivers
1.6.2 Lenalidomide Capsule Market Restraints
1.6.3 Lenalidomide Capsule Trends Analysis
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Celgene Details
2.1.2 Celgene Major Business
2.1.3 Celgene Lenalidomide Capsule Product and Services
2.1.4 Celgene Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 SL Pharma
2.2.1 SL Pharma Details
2.2.2 SL Pharma Major Business
2.2.3 SL Pharma Lenalidomide Capsule Product and Services
2.2.4 SL Pharma Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Qilu Pharma
2.3.1 Qilu Pharma Details
2.3.2 Qilu Pharma Major Business
2.3.3 Qilu Pharma Lenalidomide Capsule Product and Services
2.3.4 Qilu Pharma Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hansoh Pharma
2.4.1 Hansoh Pharma Details
2.4.2 Hansoh Pharma Major Business
2.4.3 Hansoh Pharma Lenalidomide Capsule Product and Services
2.4.4 Hansoh Pharma Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CTTQ
2.5.1 CTTQ Details
2.5.2 CTTQ Major Business
2.5.3 CTTQ Lenalidomide Capsule Product and Services
2.5.4 CTTQ Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Changzhou Pharma
2.6.1 Changzhou Pharma Details
2.6.2 Changzhou Pharma Major Business
2.6.3 Changzhou Pharma Lenalidomide Capsule Product and Services
2.6.4 Changzhou Pharma Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Yangzijiang
2.7.1 Yangzijiang Details
2.7.2 Yangzijiang Major Business
2.7.3 Yangzijiang Lenalidomide Capsule Product and Services
2.7.4 Yangzijiang Lenalidomide Capsule Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lenalidomide Capsule Breakdown Data by Manufacturer
3.1 Global Lenalidomide Capsule Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lenalidomide Capsule Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lenalidomide Capsule
3.4 Market Concentration Rate
3.4.1 Top 3 Lenalidomide Capsule Manufacturer Market Share in 2021
3.4.2 Top 6 Lenalidomide Capsule Manufacturer Market Share in 2021
3.5 Global Lenalidomide Capsule Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lenalidomide Capsule Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lenalidomide Capsule Market Size by Region
4.1.1 Global Lenalidomide Capsule Sales in Volume by Region (2017-2028)
4.1.2 Global Lenalidomide Capsule Revenue by Region (2017-2028)
4.2 North America Lenalidomide Capsule Revenue (2017-2028)
4.3 Europe Lenalidomide Capsule Revenue (2017-2028)
4.4 Asia-Pacific Lenalidomide Capsule Revenue (2017-2028)
4.5 South America Lenalidomide Capsule Revenue (2017-2028)
4.6 Middle East and Africa Lenalidomide Capsule Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lenalidomide Capsule Sales in Volume by Type (2017-2028)
5.2 Global Lenalidomide Capsule Revenue by Type (2017-2028)
5.3 Global Lenalidomide Capsule Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lenalidomide Capsule Sales in Volume by Application (2017-2028)
6.2 Global Lenalidomide Capsule Revenue by Application (2017-2028)
6.3 Global Lenalidomide Capsule Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lenalidomide Capsule Sales by Type (2017-2028)
7.2 North America Lenalidomide Capsule Sales by Application (2017-2028)
7.3 North America Lenalidomide Capsule Market Size by Country
7.3.1 North America Lenalidomide Capsule Sales in Volume by Country (2017-2028)
7.3.2 North America Lenalidomide Capsule Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lenalidomide Capsule Sales by Type (2017-2028)
8.2 Europe Lenalidomide Capsule Sales by Application (2017-2028)
8.3 Europe Lenalidomide Capsule Market Size by Country
8.3.1 Europe Lenalidomide Capsule Sales in Volume by Country (2017-2028)
8.3.2 Europe Lenalidomide Capsule Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lenalidomide Capsule Sales by Type (2017-2028)
9.2 Asia-Pacific Lenalidomide Capsule Sales by Application (2017-2028)
9.3 Asia-Pacific Lenalidomide Capsule Market Size by Region
9.3.1 Asia-Pacific Lenalidomide Capsule Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lenalidomide Capsule Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lenalidomide Capsule Sales by Type (2017-2028)
10.2 South America Lenalidomide Capsule Sales by Application (2017-2028)
10.3 South America Lenalidomide Capsule Market Size by Country
10.3.1 South America Lenalidomide Capsule Sales in Volume by Country (2017-2028)
10.3.2 South America Lenalidomide Capsule Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lenalidomide Capsule Sales by Type (2017-2028)
11.2 Middle East & Africa Lenalidomide Capsule Sales by Application (2017-2028)
11.3 Middle East & Africa Lenalidomide Capsule Market Size by Country
11.3.1 Middle East & Africa Lenalidomide Capsule Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lenalidomide Capsule Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lenalidomide Capsule and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lenalidomide Capsule
12.3 Lenalidomide Capsule Production Process
12.4 Lenalidomide Capsule Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lenalidomide Capsule Typical Distributors
13.3 Lenalidomide Capsule Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Lenalidomide Capsule Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lenalidomide Capsule Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Celgene Basic Information, Manufacturing Base and Competitors
Table 4. Celgene Major Business
Table 5. Celgene Lenalidomide Capsule Product and Services
Table 6. Celgene Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. SL Pharma Basic Information, Manufacturing Base and Competitors
Table 8. SL Pharma Major Business
Table 9. SL Pharma Lenalidomide Capsule Product and Services
Table 10. SL Pharma Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Qilu Pharma Major Business
Table 13. Qilu Pharma Lenalidomide Capsule Product and Services
Table 14. Qilu Pharma Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Hansoh Pharma Major Business
Table 17. Hansoh Pharma Lenalidomide Capsule Product and Services
Table 18. Hansoh Pharma Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CTTQ Basic Information, Manufacturing Base and Competitors
Table 20. CTTQ Major Business
Table 21. CTTQ Lenalidomide Capsule Product and Services
Table 22. CTTQ Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Changzhou Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Changzhou Pharma Major Business
Table 25. Changzhou Pharma Lenalidomide Capsule Product and Services
Table 26. Changzhou Pharma Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Yangzijiang Basic Information, Manufacturing Base and Competitors
Table 28. Yangzijiang Major Business
Table 29. Yangzijiang Lenalidomide Capsule Product and Services
Table 30. Yangzijiang Lenalidomide Capsule Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Lenalidomide Capsule Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Lenalidomide Capsule Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Lenalidomide Capsule, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Lenalidomide Capsule Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Lenalidomide Capsule Production Site of Key Manufacturer
Table 36. Lenalidomide Capsule New Entrant and Capacity Expansion Plans
Table 37. Lenalidomide Capsule Mergers & Acquisitions in the Past Five Years
Table 38. Global Lenalidomide Capsule Sales by Region (2017-2022) & (K Units)
Table 39. Global Lenalidomide Capsule Sales by Region (2023-2028) & (K Units)
Table 40. Global Lenalidomide Capsule Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Lenalidomide Capsule Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Lenalidomide Capsule Sales by Type (2017-2022) & (K Units)
Table 43. Global Lenalidomide Capsule Sales by Type (2023-2028) & (K Units)
Table 44. Global Lenalidomide Capsule Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Lenalidomide Capsule Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Lenalidomide Capsule Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Lenalidomide Capsule Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Lenalidomide Capsule Sales by Application (2017-2022) & (K Units)
Table 49. Global Lenalidomide Capsule Sales by Application (2023-2028) & (K Units)
Table 50. Global Lenalidomide Capsule Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Lenalidomide Capsule Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Lenalidomide Capsule Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Lenalidomide Capsule Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Lenalidomide Capsule Sales by Country (2017-2022) & (K Units)
Table 55. North America Lenalidomide Capsule Sales by Country (2023-2028) & (K Units)
Table 56. North America Lenalidomide Capsule Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Lenalidomide Capsule Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Lenalidomide Capsule Sales by Type (2017-2022) & (K Units)
Table 59. North America Lenalidomide Capsule Sales by Type (2023-2028) & (K Units)
Table 60. North America Lenalidomide Capsule Sales by Application (2017-2022) & (K Units)
Table 61. North America Lenalidomide Capsule Sales by Application (2023-2028) & (K Units)
Table 62. Europe Lenalidomide Capsule Sales by Country (2017-2022) & (K Units)
Table 63. Europe Lenalidomide Capsule Sales by Country (2023-2028) & (K Units)
Table 64. Europe Lenalidomide Capsule Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Lenalidomide Capsule Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Lenalidomide Capsule Sales by Type (2017-2022) & (K Units)
Table 67. Europe Lenalidomide Capsule Sales by Type (2023-2028) & (K Units)
Table 68. Europe Lenalidomide Capsule Sales by Application (2017-2022) & (K Units)
Table 69. Europe Lenalidomide Capsule Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Lenalidomide Capsule Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Lenalidomide Capsule Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Lenalidomide Capsule Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Lenalidomide Capsule Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Lenalidomide Capsule Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Lenalidomide Capsule Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Lenalidomide Capsule Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Lenalidomide Capsule Sales by Application (2023-2028) & (K Units)
Table 78. South America Lenalidomide Capsule Sales by Country (2017-2022) & (K Units)
Table 79. South America Lenalidomide Capsule Sales by Country (2023-2028) & (K Units)
Table 80. South America Lenalidomide Capsule Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Lenalidomide Capsule Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Lenalidomide Capsule Sales by Type (2017-2022) & (K Units)
Table 83. South America Lenalidomide Capsule Sales by Type (2023-2028) & (K Units)
Table 84. South America Lenalidomide Capsule Sales by Application (2017-2022) & (K Units)
Table 85. South America Lenalidomide Capsule Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Lenalidomide Capsule Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Lenalidomide Capsule Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Lenalidomide Capsule Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Lenalidomide Capsule Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Lenalidomide Capsule Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Lenalidomide Capsule Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Lenalidomide Capsule Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Lenalidomide Capsule Sales by Application (2023-2028) & (K Units)
Table 94. Lenalidomide Capsule Raw Material
Table 95. Key Manufacturers of Lenalidomide Capsule Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Lenalidomide Capsule Typical Distributors
Table 99. Lenalidomide Capsule Typical Customers
List of Figures
Figure 1. Lenalidomide Capsule Picture
Figure 2. Global Lenalidomide Capsule Revenue Market Share by Type in 2021
Figure 3. 5 mg Capsules
Figure 4. 10 mg Capsules
Figure 5. 15 mg Capsules
Figure 6. 25 mg Capsules
Figure 7. Global Lenalidomide Capsule Revenue Market Share by Application in 2021
Figure 8. Multiple myeloma (MM)
Figure 9. Myelodysplastic syndromes (MDS)
Figure 10. Global Lenalidomide Capsule Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Lenalidomide Capsule Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Lenalidomide Capsule Sales (2017-2028) & (K Units)
Figure 13. Global Lenalidomide Capsule Price (2017-2028) & (US$/Unit)
Figure 14. Global Lenalidomide Capsule Production Capacity (2017-2028) & (K Units)
Figure 15. Global Lenalidomide Capsule Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Lenalidomide Capsule Market Drivers
Figure 17. Lenalidomide Capsule Market Restraints
Figure 18. Lenalidomide Capsule Market Trends
Figure 19. Global Lenalidomide Capsule Sales Market Share by Manufacturer in 2021
Figure 20. Global Lenalidomide Capsule Revenue Market Share by Manufacturer in 2021
Figure 21. Lenalidomide Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Lenalidomide Capsule Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Lenalidomide Capsule Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Lenalidomide Capsule Sales Market Share by Region (2017-2028)
Figure 25. Global Lenalidomide Capsule Revenue Market Share by Region (2017-2028)
Figure 26. North America Lenalidomide Capsule Revenue (2017-2028) & (USD Million)
Figure 27. Europe Lenalidomide Capsule Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Lenalidomide Capsule Revenue (2017-2028) & (USD Million)
Figure 29. South America Lenalidomide Capsule Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Lenalidomide Capsule Revenue (2017-2028) & (USD Million)
Figure 31. Global Lenalidomide Capsule Sales Market Share by Type (2017-2028)
Figure 32. Global Lenalidomide Capsule Revenue Market Share by Type (2017-2028)
Figure 33. Global Lenalidomide Capsule Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Lenalidomide Capsule Sales Market Share by Application (2017-2028)
Figure 35. Global Lenalidomide Capsule Revenue Market Share by Application (2017-2028)
Figure 36. Global Lenalidomide Capsule Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Lenalidomide Capsule Sales Market Share by Type (2017-2028)
Figure 38. North America Lenalidomide Capsule Sales Market Share by Application (2017-2028)
Figure 39. North America Lenalidomide Capsule Sales Market Share by Country (2017-2028)
Figure 40. North America Lenalidomide Capsule Revenue Market Share by Country (2017-2028)
Figure 41. United States Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Lenalidomide Capsule Sales Market Share by Type (2017-2028)
Figure 45. Europe Lenalidomide Capsule Sales Market Share by Application (2017-2028)
Figure 46. Europe Lenalidomide Capsule Sales Market Share by Country (2017-2028)
Figure 47. Europe Lenalidomide Capsule Revenue Market Share by Country (2017-2028)
Figure 48. Germany Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Lenalidomide Capsule Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Lenalidomide Capsule Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Lenalidomide Capsule Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Lenalidomide Capsule Revenue Market Share by Region (2017-2028)
Figure 57. China Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Lenalidomide Capsule Sales Market Share by Type (2017-2028)
Figure 64. South America Lenalidomide Capsule Sales Market Share by Application (2017-2028)
Figure 65. South America Lenalidomide Capsule Sales Market Share by Country (2017-2028)
Figure 66. South America Lenalidomide Capsule Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Lenalidomide Capsule Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Lenalidomide Capsule Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Lenalidomide Capsule Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Lenalidomide Capsule Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Lenalidomide Capsule Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Lenalidomide Capsule in 2021
Figure 78. Manufacturing Process Analysis of Lenalidomide Capsule
Figure 79. Lenalidomide Capsule Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • レナリドマイド薬のグローバル市場展望 2023年-2029年：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル
  • 世界のレボノルゲストレカプセル市場2022年：市場規模予測（～2028年）
  • レボノルゲストレカプセル剤のグローバル市場展望 2023年-2029年：1パック、2パック
  • 世界の医薬品用空カプセル市場2022年：市場規模予測（～2028年）
  • 世界の一体型ソフトカプセル市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19713 )"世界のレナリドミドカプセル市場2022年：市場規模予測（～2028年）" (英文：Global Lenalidomide Capsule Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。